2010 annual financial data
Nektar Therapeutics 2010 Operating margin
Nektar Therapeutics 2010 operating margin with verified reported values.
Direct answer
Operating margin was -17.77%.
Operating income was -28,255,000 USD and net income was -37,938,000 USD.
Operating cash flow was -55,871,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 159,039,000 USD
- Operating income
- -28,255,000 USD
- Net income
- -37,938,000 USD
- Operating cash flow
- -55,871,000 USD